RETRACTED ARTICLE: Correlation of Promoter Methylation in the MGMT Gene with Glioma Risk and Prognosis: a Meta-Analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RETRACTED ARTICLE: Correlation of Promoter Methylation in the MGMT Gene with Glioma Risk and Prognosis: a Meta-Analysis
Authors
Keywords
Promoter Methylation, Review Process, Strong Reason, Peer Review Process, Publication Ethic
Journal
MOLECULAR NEUROBIOLOGY
Volume 52, Issue 3, Pages 1887-1887
Publisher
Springer Nature
Online
2014-06-11
DOI
10.1007/s12035-014-8760-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk
- (2013) Mahboobeh Safaeian et al. CANCER CAUSES & CONTROL
- The mitonuclear compatibility hypothesis of sexual selection
- (2013) G. E. Hill et al. PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Allergic conditions reduce the risk of glioma: a meta-analysis based on 128,936 subjects
- (2013) Hongyu Zhao et al. TUMOR BIOLOGY
- Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis
- (2013) Zhiqin Xu et al. TUMOR BIOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009
- (2012) T. A. Dolecek et al. NEURO-ONCOLOGY
- The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations
- (2010) Andreas Von Deimling et al. BRAIN PATHOLOGY
- Extent and Patterns of MGMT Promoter Methylation in Glioblastoma- and Respective Glioblastoma-Derived Spheres
- (2010) D. Sciuscio et al. CLINICAL CANCER RESEARCH
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation
- (2009) Philippe Metellus et al. CANCER
- Epigenetics in cancer
- (2009) S. Sharma et al. CARCINOGENESIS
- Epigenetic Silencing of Death Receptor 4 Mediates Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance in Gliomas
- (2009) A. Elias et al. CLINICAL CANCER RESEARCH
- Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
- (2009) J. Felsberg et al. CLINICAL CANCER RESEARCH
- Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O6-methylguanine-DNA methyltransferaseP140K
- (2009) P Maier et al. GENE THERAPY
- Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods
- (2009) Lucie Karayan-Tapon et al. JOURNAL OF NEURO-ONCOLOGY
- Effects of O6-methylguanine-DNA methyltransferase (MGMT) polymorphisms on cancer: a meta-analysis
- (2009) Y. Zhong et al. MUTAGENESIS
- MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
- (2009) Michael Weller et al. Nature Reviews Neurology
- Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
- (2008) Monika E. Hegi et al. JOURNAL OF CLINICAL ONCOLOGY
- Validation of Real-Time Methylation-Specific PCR to Determine O6-Methylguanine-DNA Methyltransferase Gene Promoter Methylation in Glioma
- (2008) Ilse Vlassenbroeck et al. JOURNAL OF MOLECULAR DIAGNOSTICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started